Cardiff Oncology

(NASDAQ) CRDF

Current Price$1.77

Market Cap$122.38M

Since IPO (2004)-100%

5 Year-77%

1 Year-38%

1 Month+8%

Cardiff Oncology Financials at a Glance

Market Cap

$122.38M

Revenue (TTM)

$525.00K

Net Income (TTM)

$44.77M

EPS (TTM)

$-0.67

P/E Ratio

-2.69

Dividend

$0.00

Beta (Volatility)

1.72 (High)

Dividend

$0.00

Beta (Volatility)

1.72 (High)

Price

$1.77

Volume

1,262,113

Open

$1.81

Price

$1.77

Volume

1,262,113

Open

$1.81

Previous Close

$1.78

Daily Range

$1.68 - $1.82

52-Week Range

$1.48 - $4.55

Dividend

$0.00

Beta (Volatility)

1.72 (High)

Price

$1.77

Volume

1,262,113

Open

$1.81

Previous Close

$1.78

Daily Range

$1.68 - $1.82

52-Week Range

$1.48 - $4.55

CRDF News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cardiff Oncology

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Mani Mohindru, PhD

Website

www.cardiffoncology.com

Headquarters

San Diego, CA 92121, US

CRDF Financials

Key Financial Metrics (TTM)

Gross Margin

-21%

Operating Margin

-90%

Net Income Margin

-85%

Return on Equity

-85%

Return on Capital

-1%

Return on Assets

-91%

Earnings Yield

-37.17%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$122.38M

Shares Outstanding

68.37M

Volume

1.26M

Avg. Volume

789.66K

Financials (TTM)

Gross Profit

$593.00K

Operating Income

$48.96M

EBITDA

$48.06M

Operating Cash Flow

$37.92M

Capital Expenditure

$44.00K

Free Cash Flow

$37.97M

Cash & ST Invst.

$58.30M

Total Debt

$832.00K

Cardiff Oncology Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$41.00K

-62.4%

Gross Profit

$180.00K

-265.1%

Gross Margin

-4.39%

N/A

Market Cap

$122.38M

N/A

Market Cap/Employee

$3.82M

N/A

Employees

N/A

Net Income

$12.35M

+8.1%

EBITDA

$12.63M

+10.8%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Net Cash

$45.41M

-42.2%

Accounts Receivable

$191.00K

-52.8%

Inventory

$0.00

N/A

Long Term Debt

$0.00

-100.0%

Short Term Debt

$646.00K

-9.8%

Return on Assets

-91.04%

N/A

Return on Invested Capital

-1.37%

N/A

Free Cash Flow

$12.29M

+4.0%

Operating Cash Flow

$12.29M

+4.0%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

MISTMilestone Pharmaceuticals Inc.

MISTMilestone Pharmaceuticals Inc.$1.41-7.24%

PEPGPepGen Inc.

PEPGPepGen Inc.$1.51-1.95%

CRBPCorbus Pharmaceuticals Holdings, Inc.

CRBPCorbus Pharmaceuticals Holdings, Inc.$11.35-1.39%

MOLNMolecular Partners AG

MOLNMolecular Partners AG$4.18+10.00%

IPHAInnate Pharma S.A.

IPHAInnate Pharma S.A.$1.83-7.11%

RANIRani Therapeutics Holdings, Inc.

RANIRani Therapeutics Holdings, Inc.$1.07+0.00%

ELTXElicio Therapeutics, Inc.

ELTXElicio Therapeutics, Inc.$9.95+0.51%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$15.47+0.09%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.85+0.02%

NIONio

NIONio$5.20-0.07%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.26+0.04%

INFQInfleqtion

INFQInfleqtion $16.35+0.11%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.84+0.01%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.50-0.01%

Questions About CRDF

What is the current price of Cardiff Oncology?

Cardiff Oncology is trading at $1.78 per share.

What is the 52-week range for Cardiff Oncology?

Over the past 52 weeks, Cardiff Oncology has traded between $1.48 and $4.56.

How much debt does Cardiff Oncology have?

As of the most recent reporting period, Cardiff Oncology reported total debt of $646,000.

How much cash does Cardiff Oncology have on hand?

Cardiff Oncology reported $8.54M in cash and cash equivalents in its most recent financial results.

What is Cardiff Oncology’s dividend yield?

Cardiff Oncology does not currently have a dividend yield.

Cardiff Oncology

Cardiff Oncology Financials at a Glance

CRDF News

Cardiff Oncology (CRDF) Q2 Loss Down 19%

These 2 Nasdaq Stocks Are Poised to Make Big Moves Today

1 Cancer Stock on Buyout Watch in 2022

Why Cardiff Oncology Shares Were Up More Than 15% on Thursday

Why Shares of Cardiff Oncology Rose on Monday

Why Cardiff Oncology Ran Up 1,350% in 2020

Why Cardiff Oncology Stock Is Crashing Today

2 Biotech Stocks That Keep on Climbing

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cardiff Oncology

CRDF Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cardiff Oncology Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CRDF

What is the current price of Cardiff Oncology?

What is the 52-week range for Cardiff Oncology?

How much debt does Cardiff Oncology have?

How much cash does Cardiff Oncology have on hand?

What is Cardiff Oncology’s dividend yield?

Premium Investing Services